Good MorningResilient equity markets were able to advance in the prior week. The S&P 500 gained more than 1% to trade just shy of record highs. The move came in the face of hot inflation and weak retail sales data, revealing a market focused on earnings and capital returns, which are expected to grow robustly this year.
Next week's hurdles center around the FOMC minutes. The minutes will likely reveal a hawkish Fed and affirm the diminished expectations for interest rate reduction this year. Featured: How to get a stake in Anthropic — before the IPO (Ad) 
|
Industrials | |
Markets have hit shares of robotic warehouse systems company Symbotic (NASDAQ: SYM) hard over the past 52 weeks. Shares of the industrials stock have lost nearly 37% of their value as of the Feb. 13 close. Retail giant Walmart (NYSE: WMT) is a huge Symbotic customer, a testament to the company&rsq... Read the Full Story |
|
From Our Partners | | Trump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up.
One day it's a ceasefire, the next it's bombs again. The back and forth may be masking a bigger story most investors are missing.
See the real reason this conflict may never fully end. | | Uncover the real reason Trump may never end this war |
|
Consumer Discretionary | |
Discount retailers have become an attractive investment opportunity due to the current economic climate of persistent inflation. As consumers face rising costs for goods and services, the appeal of discount retailers, who offer consistently lower prices than traditional retail sector outlets, grow... Read the Full Story |
|
Communication Services | |
Roblox (NYSE: RBLX), one of the hotter stocks in the gaming industry over the past 52 weeks, just had much of its 2025 gains wiped out. Prior to the company’s latest earnings report, shares were up over 30% on the year. As of the Feb. 13 close, markets have pared those gains down to just 1... Read the Full Story |
|
From Our Partners | | A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of Saudi Arabia's largest oil field, with potential to last two million years.
While the One Big Beautiful Bill Act eliminated federal credits for solar, wind, and EVs, this energy source was reclassified alongside oil and nuclear power and given eight years of tax credits. Google signed a 15-year contract, and Bill Gates committed $100 million.
One company controls the entire supply chain behind this discovery. | | See the ticker behind this Grand Canyon energy breakthrough now |
|
Energy | |
Chevron Corp. (NYSE: CVX) announced it was laying off approximately 20% of its global workforce by the end of 2026. The company announced the moves as an effort to cut costs, simplify its business, and complete its ongoing merger with Hess Corp. (NYSE: HES).
After falling about 2% on the announce... Read the Full Story |
|
Markets | |
As reports that inflation heated up in January 2025 emerged on February 12, the market shuddered, with the Dow dropping by more than 300 points in morning trading. The recent Consumer Price Index report may be enough to prompt investors to take a cautious stance, particularly as the impact of rece... Read the Full Story |
|
From Our Partners | | Last month, the Fed raised rates for the first time in three years. Inflation won't go away. And the AI boom that's carried this market for years is starting to look shaky... One major research firm calls it a "late-stage bubble" and is warning the market could fall 30% or more from its high.
If the crash comes, younger investors get knocked down and get back up. They have paychecks. They have time. Retirees don't get that luxury.
Just ask anyone who retired in 2008. Plans that looked bulletproof were gutted in months. People who did everything right were forced back to work... or forced to watch their account shrink year after year. Their plan never asked the one question that mattered: What happens if the crash comes at the worst possible time? | | Take the free 2-minute quiz to see where your retirement stands. |
|
Consumer Discretionary | | The market’s memory is still fresh when it comes to the volatility induced by the NVIDIA Co. (NASDAQ: NVDA) flash sell-off that came from the DeepSeek debacle in China. However, the relationship between NVIDIA and China goes well beyond that recent incident. What investors may or may not know ... Read the Full Story |
|
Technology | |
Twilio’s (NYSE: TWLO) pullback is the time to buy this stock because it offers an opportune discount in a high-quality tech-growth stock with AI and automation exposure. The stock price rose by 50% in January, extending a trend that began in 2024 and was driven by reinvigorated growth and ... Read the Full Story |
|
Materials | |
There comes a time every once in a cycle when the market gets too invested in either a bullish or bearish view, and just like any other physical marketplace, the stock market can then trigger a major shift to the opposite end of this concentrated view. Investors can imagine the bottlenecks and man... Read the Full Story |
|
Technology | |
Cisco Systems (NASDAQ: CSCO) latest earnings report exceeded analyst expectations, indicating a potential resurgence for the technology company. As a result, Cisco's stock price rose to new yearly highs, and investor confidence was seemingly renewed.
Additionally, Cisco announced a stock buybac... Read the Full Story |
|
Materials | |
Investors are typically – and justifiably – careful about investing in any given stock around the company’s earnings season since volatility is usually elevated for the days before, during, and after the financial announcements. However, every once in a while, the market will giv... Read the Full Story |
|
Monday's Early Bird Stock Of The Day BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer. The company is also developing Bria-OTS, a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical studies targeting breast cancer with extension to prostate cancer and other cancers. BriaCell Therapeutics Corp. is based in West Vancouver, Canada. | | View Today's Stock Pick |
|
